A detailed history of Latitude Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Latitude Advisors, LLC holds 3,505 shares of MRK stock, worth $384,743. This represents 0.31% of its overall portfolio holdings.

Number of Shares
3,505
Previous 4,207 16.69%
Holding current value
$384,743
Previous $555,000 21.98%
% of portfolio
0.31%
Previous 0.4%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$123.8 - $132.96 $86,907 - $93,337
-702 Reduced 16.69%
3,505 $433,000
Q1 2024

Apr 25, 2024

SELL
$113.24 - $131.95 $141,097 - $164,409
-1,246 Reduced 22.85%
4,207 $555,000
Q4 2023

Jan 30, 2024

BUY
$100.18 - $109.02 $4,007 - $4,360
40 Added 0.74%
5,453 $594,000
Q3 2023

Nov 03, 2023

SELL
$102.95 - $114.33 $6,177 - $6,859
-60 Reduced 1.1%
5,413 $557,000
Q2 2023

Jul 26, 2023

BUY
$108.61 - $118.38 $51,263 - $55,875
472 Added 9.44%
5,473 $631,000
Q1 2023

Apr 27, 2023

BUY
$102.94 - $114.86 $8,544 - $9,533
83 Added 1.69%
5,001 $532,000
Q4 2022

Jan 27, 2023

SELL
$87.44 - $112.11 $41,009 - $52,579
-469 Reduced 8.71%
4,918 $0
Q3 2022

Nov 01, 2022

BUY
$84.53 - $94.96 $37,446 - $42,067
443 Added 8.96%
5,387 $464,000
Q2 2022

Jul 28, 2022

SELL
$83.49 - $94.64 $779,546 - $883,653
-9,337 Reduced 65.38%
4,944 $450,000
Q1 2022

Apr 29, 2022

BUY
$73.51 - $82.4 $77,553 - $86,932
1,055 Added 7.98%
14,281 $1.17 Million
Q4 2021

Jan 18, 2022

BUY
$72.28 - $90.54 $80,158 - $100,408
1,109 Added 9.15%
13,226 $1.01 Million
Q3 2021

Oct 14, 2021

BUY
$71.68 - $78.83 $465,991 - $512,473
6,501 Added 115.76%
12,117 $910,000
Q2 2021

Jul 20, 2021

SELL
$70.31 - $77.77 $9,491 - $10,498
-135 Reduced 2.35%
5,616 $437,000
Q1 2021

Apr 14, 2021

SELL
$68.86 - $81.11 $4,407 - $5,191
-64 Reduced 1.1%
5,751 $443,000
Q4 2020

Feb 04, 2021

BUY
$71.77 - $79.65 $417,342 - $463,164
5,815 New
5,815 $476,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $278B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Latitude Advisors, LLC Portfolio

Follow Latitude Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Latitude Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Latitude Advisors, LLC with notifications on news.